Northwest Biothrputcs Inc
(NWBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,663 | -113,278 | -46,433 | -135,634 | -92,949 |
| Depreciation Amortization | 1,057 | 732 | 237 | 223 | 473 |
| Accounts payable and accrued liabilities | N/A | N/A | -378 | N/A | N/A |
| Other Working Capital | 7,974 | -163 | -554 | 24,092 | 19,141 |
| Other Operating Activity | 25,151 | 68,025 | 29,546 | 56,743 | 37,355 |
| Operating Cash Flow | $-56,481 | $-44,684 | $-17,582 | $-54,576 | $-35,980 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,010 | -2,015 | -1,133 | -33,727 | -22,332 |
| Other Investing Activity | 0 | 0 | 0 | -2,625 | -2,625 |
| Investing Cash Flow | $-4,010 | $-2,015 | $-1,133 | $-36,352 | $-24,957 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,997 | 4,997 | 4,997 | 24,490 | 16,220 |
| Debt Repayment | N/A | N/A | N/A | -25 | -25 |
| Common Stock Issued | 47,431 | 40,000 | 3,651 | 63,256 | 28,751 |
| Other Financing Activity | 149 | 6,716 | -138 | -1,902 | -1,105 |
| Financing Cash Flow | $52,577 | $51,713 | $8,510 | $85,819 | $43,841 |
| Exchange Rate Effect | -84 | 798 | -15 | N/A | N/A |
| Beginning Cash Position | 13,390 | 13,390 | 13,390 | 18,499 | 18,499 |
| End Cash Position | 5,392 | 19,202 | 3,170 | 13,390 | 1,403 |
| Net Cash Flow | $-7,998 | $5,812 | $-10,220 | $-5,109 | $-17,096 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,481 | -44,684 | -17,582 | -54,576 | -35,980 |
| Capital Expenditure | -4,010 | -2,015 | -1,133 | -33,727 | -22,332 |
| Free Cash Flow | -60,491 | -46,699 | -18,715 | -88,303 | -58,312 |